ARCHIVES

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

This article is from The Cancer Letter archive.

Vol. 40 No. 01 | January 3, 2014

Download PDF Visit The Full Archive

Related Articles

Also: CALGB elects Schilsky to third term as chairman.

July 16, 2004

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

June 13, 1980

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986

Finally, An FY01 Appropriation For NIH; NCI’s Share $3.757 Billion, A 13.5% Raise.

January 5, 2001